Budget Impact Analysis of the use of emicizumab for bleeding prophylaxis in patients with Hemophilia A with inhibitors in the Brazilian Health System

Hemophilia A is a hereditary hemorrhagic disorder characterized by deficiency or dysfunction of the coagulation protein factor VIII. The standard therapy consists of factor VIII replacement, which can lead to the development of neutralizing antibodies (inhibitors), a major complication that implies...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Nicolas Segre (Auteur), Verónica Elizabeth Malta (Auteur), Tamiê de Camargo Martins (Auteur)
Formaat: Boek
Gepubliceerd in: Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia, 2022-12-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar